The Journal of Immunology, Vol 153, Issue 11 5091-5103, Copyright © 1994 by American Association of Immunologists

ARTICLES

Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages

C Morishima, C Norby-Slycord, KR McConnell, RJ Finch, AJ Nelson, AG Farr and AM Pullen
Department of Immunology, University of Washington, Seattle 98195.

Mouse mammary tumor virus proviral integrants encode superantigens. Developing thymocytes bearing TCRs with particular V beta elements encounter these endogenous viral superantigens as self molecules in the thymus and are consequently clonally eliminated. To study this mechanism of tolerance induction, we have bred B10.BR-Mtv-1 and B10.BR- Mtv-6 mice, which carry either Mtv-1 or Mtv-6 proviruses but are otherwise genetically identical. The protein products of these mouse mammary tumor virus integrants, vSAG1 and vSAG6, both interact with V beta 3+ T cells and have identical amino acid sequences. Interestingly, vSAG6 expression results in the complete deletion of V beta 3+ peripheral T cells, whereas vSAG1 expression results in only partial deletion. Flow cytometric analyses indicate that B10.BR-Mtv-6 mice delete V beta 3+ thymocytes at the immature CD4+8+ stage, whereas B10.BR-Mtv-1 mice delete only mature CD4+ or CD8+ cells. In addition, the two strains exhibit different time courses of thymic deletion: neonatal B10.BR-Mtv-6 mice eliminate V beta 3+ T cells by day 2, in contrast to B10.BR-Mtv-1 mice in which deletion does not occur until day 15. RNase protection assays demonstrate that B10.BR-Mtv-6 mice have significantly greater thymic vSAG6 mRNA expression levels than vSAG1 levels in B10.BR-Mtv-1 animals, correlating with a more complete deletion of reactive thymocytes at an earlier point in the maturational sequence.

This article has been cited by other articles:

				H. J. Cho, S. G. Edmondson, A. D. Miller, M. Sellars, S. T. Alexander, S. Somersan, and J. A. Punt Cutting Edge: Identification of the Targets of Clonal Deletion in an Unmanipulated Thymus J. Immunol., January 1, 2003; 170(1): 10 - 13. [Abstract] [Full Text] [PDF]

				J. A. Williams, S. O. Sharrow, A. J. Adams, and R. J. Hodes CD40 Ligand Functions Non-Cell Autonomously to Promote Deletion of Self-Reactive Thymocytes J. Immunol., March 15, 2002; 168(6): 2759 - 2765. [Abstract] [Full Text] [PDF]

				A. Barnett, F. Mustafa, T. J. Wrona, M. Lozano, and J. P. Dudley Expression of Mouse Mammary Tumor Virus Superantigen mRNA in the Thymus Correlates with Kinetics of Self-Reactive T-Cell Loss J. Virol., August 1, 1999; 73(8): 6634 - 6645. [Abstract] [Full Text]

				N. Dautigny, A. Le Campion, and B. Lucas Timing and Casting for Actors of Thymic Negative Selection J. Immunol., February 1, 1999; 162(3): 1294 - 1302. [Abstract] [Full Text] [PDF]

				A. G. Farr and A. Rudensky Medullary Thymic Epithelium: A Mosaic of Epithelial "Self"? J. Exp. Med., July 1, 1998; 188(1): 1 - 4. [Full Text] [PDF]

				D. M. Page, E. M. Roberts, J. J. Peschon, and S. M. Hedrick TNF Receptor-Deficient Mice Reveal Striking Differences Between Several Models of Thymocyte Negative Selection J. Immunol., January 1, 1998; 160(1): 120 - 133. [Abstract] [Full Text] [PDF]

				I. Ferrero, F. Anjuere, H. Robson MacDonald, and C. Ardavin In Vitro Negative Selection of Viral Superantigen-Reactive Thymocytes by Thymic Dendritic Cells Blood, September 1, 1997; 90(5): 1943 - 1951. [Abstract] [Full Text] [PDF]

				M Iwata, Y Ohoka, T Kuwata, and A Asada Regulation of T cell apoptosis via T cell receptors and steroid receptors Stem Cells, November 1, 1996; 14(6): 632 - 641. [Abstract]